Combination Therapy of Ursodeoxycholic Acid and Corticosteroids for Primary Biliary Cirrhosis with Features of Autoimmune Hepatitis: A Meta-Analysis

Table 2

Baseline characteristics of the trials included in the meta-analysis.

Authors	Mean age (years)	Monotherapy (n)	Combination therapy (n)	UDCA dose (mg·kg^−1·d^−1)	Corticosteroids dose (mg·kg^−1·d^−1)	Duration of treatment	Publication type
Chazouillères et al. [4]	50	5	6	13–15	0.5	23 m	Full text
Günsar et al. [21]	44	13	7	13	0.5	28 m	Full text
Chazouillères et al. [16]	41	11	6	13–15	0.5	90 m	Full text
Heurgué et al. [18]	44	9	4	11–14.7	0.5–1	60 m	Full text
Ozaslan et al. [20]	44	3	9	13–15	0.5	31 m	Full text
Tanaka et al. [17]	54	15	10	10	0.5	73 m	Full text
Zhu et al. [19]	50	11	8	13–15	0.5–1	10 m	Full text